PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions

AC Immune SA (ACIU)

Equity · Currency in USD · Last updated Nov 23, 2023
SummaryFinancials

Company Info

ISINCH0329023102
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$251.49M
EPS-$0.93
Revenue (TTM)$1.00K
Gross Profit (TTM)-$56.40M
EBITDA (TTM)-$67.06M
Year Range$1.68 - $3.83
Target Price$10.37
Short %1.18%
Short Ratio10.99

Share Price Chart


Loading data...

Performance

The chart shows the growth of an initial investment of $10,000 in AC Immune SA, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%20.00%40.00%60.00%JuneJulyAugustSeptemberOctoberNovember
44.30%
9.77%
ACIU (AC Immune SA)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ACIU

AC Immune SA

Return

AC Immune SA had a return of 48.53% year-to-date (YTD) and 12.22% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date48.53%18.68%
1 month14.34%8.05%
6 months34.67%10.73%
1 year12.22%13.81%
5 years (annualized)-22.48%11.63%
10 years (annualized)N/A9.72%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2023-17.09%12.37%35.55%1.52%8.33%-12.31%5.26%

Risk-Adjusted Performance

This table presents a comparison of risk-adjusted performance metrics for AC Immune SA (ACIU) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
ACIU
AC Immune SA
0.15
^GSPC
S&P 500
1.07

Sharpe Ratio

The current AC Immune SA Sharpe ratio is 0.15. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.


Rolling 12-month Sharpe Ratio-0.500.000.501.00JuneJulyAugustSeptemberOctoberNovember
0.15
1.07
ACIU (AC Immune SA)
Benchmark (^GSPC)

Dividend History


AC Immune SA doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-84.30%
-5.00%
ACIU (AC Immune SA)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the AC Immune SA. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the AC Immune SA was 91.09%, occurring on Dec 22, 2022. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-91.09%Sep 29, 20161570Dec 22, 2022

Volatility Chart

The current AC Immune SA volatility is 21.08%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%60.00%JuneJulyAugustSeptemberOctoberNovember
21.08%
3.78%
ACIU (AC Immune SA)
Benchmark (^GSPC)

Recent discussions